Skip to main content

Table 1 Five-year cumulative incidences of death among patients with melanoma

From: Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis

   

Cause-specific death

Death from other causes

Characteristics

N (%)

Event

5-year (%)

P

5-year (%)

P

Total

40043

7216

7.1 (6.8 to 7.3)

 

7.4 (7.1 to 7.6)

 

Age (years)

   

< 0.001

 

< 0.001

 20–39 years

5940 (14.8)

262

3.3 (2.8 to 3.7)

 

0.4 (0.3 to 0.6)

 

 40–64 years

20766 (51.9)

2069

5.7 (5.4 to 6.0)

 

2.3 (2.1 to 2.5)

 

 65+ years

13337 (33.3)

4885

10.8 (10.3 to 11.3)

 

18.2 (17.5 to 18.9)

 

Sex

   

< 0.001

 

< 0.001

 Male

22295 (55.7)

4901

8.7 (8.3 to 9.1)

 

8.9 (8.5 to 9.3)

 

 Female

17748 (44.3)

2315

5.0 (4.7 to 5.3)

 

5.4 (5.1 to 5.8)

 

Race

   

< 0.001

 

0.006

 White

39559 (98.8)

7075

6.9 (6.6 to 7.1)

 

7.4 (7.1 to 7.7)

 

 Non-white

484 (1.2)

141

20.7 (17.2 to 24.4)

 

4.2 (2.7 to 6.3)

 

Melanoma subtype

   

< 0.001

 

< 0.001

 Superficial spreading melanoma

13444 (33.6)

1645

3.9 (3.6 to 4.2)

 

5.4 (5.0 to 5.8)

 

 Nodular melanoma

2875 (7.2)

1233

25.6 (24.0 to 27.2)

 

12.1 (10.9 to 13.3)

 

 Lentigo maligna melanoma

2383 (6.0)

547

3.4 (2.7 to 4.2)

 

14.5 (13.1 to 16.0)

 

 Melanoma, NOS

18926 (47.3)

3131

6.2 (5.9 to 6.5)

 

6.9 (6.5 to 7.3)

 

 Others

2415 (6.0)

660

12.8 (11.5 to 14.2)

 

9.2 (8.1 to 10.4)

 

Anatomic sites

   

< 0.001

 

<0.001

 Extremities

18427 (46.0)

2811

5.9 (5.6 to 6.3)

 

6.2 (5.9 to 6.6)

 

 Trunk

13987 (34.9)

2250

6.9 (6.5 to 7.3)

 

5.9 (5.5 to 6.3)

 

 Face and ears

4819 (12.0)

1331

8.0 (7.2 to 8.8)

 

13.8 (12.8 to 14.8)

 

 Scalp and neck

2810 (7.0)

824

13.9 (12.6 to 15.2)

 

10.8 (9.6 to 11.9)

 

Thickness (mm)

   

< 0.001

 

< 0.001

  ≤ 1.00

28017 (70.0)

3086

2.2 (2.0 to 2.4)

 

5.9 (5.7 to 6.3)

 

 1.01–2.00

6279 (15.7)

1415

9.4 (8.7 to 10.2)

 

8.1 (7.5 to 8.8)

 

 2.01–4.00

3464 (8.9)

1391

21.2 (19.9 to 22.6)

 

11.8 (10.8 to 12.9)

 

  > 4.00

2283 (5.7)

1324

38.1 (36.1 to 40.1)

 

15.2 (13.7 to 16.7)

 

Ulceration

   

< 0.001

 

< 0.001

 Absent

35065 (87.6)

4916

4.1 (3.9 to 4.3)

 

6.6 (6.3 to 6.8)

 

 Present

4978 (12.4)

2300

27.6 (26.4 to 28.9)

 

12.8 (11.9 to 13.8)

 

Lymph node status

   

< 0.001

 

< 0.001

 N0

37363 (93.3)

5889

4.8 (4.6 to 5.0)

 

7.4 (7.1 to 7.7)

 

 N1

1543 (3.9)

650

31.0 (28.7 to 33.4)

 

6.0 (4.9 to 7.3)

 

 N2

762 (1.9)

401

38.8 (35.5 to 42.3)

 

7.8 (6.0 to 9.9)

 

 N3

375 (0.9)

276

63.8 (58.7 to 68.5)

 

6.2 (4.0 to 8.9)

 

Stage

   

<0.001

 

< 0.001

 I/II

37363 (93.3)

5889

4.8 (4.6 to 5.0)

 

7.4 (7.1 to 7.7)

 

 III

2680 (6.7)

1327

37.8 (36.0–39.7)

 

6.5 (5.7–7.5)

 
  1. Abbreviation: NOS malignant melanoma, not otherwise specified